Placement Pending

Candid Therapeutics placement

US$505m raised

Announced 2 Mar 2026

Advisers

Issuer
Candid Therapeutics
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.